SRBCF (Sirona Biochem) Inventories, Raw Materials & Components : $0.00 Mil (As of Jul. 2024)

View and export this data going back to 2009. Start your Free Trial

What is Sirona Biochem Inventories, Raw Materials & Components?

Sirona Biochem's inventories, raw materials & components for the quarter that ended in Jul. 2024 was $0.00 Mil.

Sirona Biochem Inventories, Raw Materials & Components Historical Data

The historical data trend for Sirona Biochem's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sirona Biochem Inventories, Raw Materials & Components Chart

Sirona Biochem Annual Data

Trend

Oct14

Oct15

Oct16

Oct17

Oct18

Oct19

Oct20

Oct21

Oct22

Oct23

Inventories, Raw Materials & Components

Get a 7-Day Free Trial

Sirona Biochem Quarterly Data
	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24
Inventories, Raw Materials & Components	Get a 7-Day Free Trial															-	-	-	-	-

Sirona Biochem Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.

Sirona Biochem Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sirona Biochem Corp (OTCPK:SRBCF) » Definitions » Inventories, Raw Materials & Components

Comparable Companies

Traded in Other Exchanges

ZSB:Germany SBM:Canada

Address

C/o WeWork, 595 Burrard Street, Vancouver, BC, CAN, V7X 1L4

Website

https://www.sironabiochem.com

Sirona Biochem Corp is a development stage biotechnology company. The principal activities of the company are the development of cosmetic and pharmaceutical active ingredients which are licensed to partners in exchange for upfront, milestone, and royalty payments. The company acts as a cosmetic ingredient and drug discovery company with a proprietary technology platform with a specialization in the stabilization of carbohydrate molecules. The company has a business presence in Canada and France.